CORC

浏览/检索结果: 共12条,第1-10条 帮助

已选(0)清除 条数/页:   排序方式:
Phase III HEAT Study Adding Lyso-Thermosensitive Liposomal Doxorubicin to Radiofrequency Ablation in Patients with Unresectable Hepatocellular Carcinoma Lesions 期刊论文
Clinical Cancer Research, 2018, 卷号: 24, 期号: 1, 页码: 73-83
作者:  Tak, Won Young*;  Lin, Shi-Ming;  Wang, Yijun;  Zheng, Jiasheng;  Vecchione, Aldo
收藏  |  浏览/下载:4/0  |  提交时间:2019/12/03
Phase III HEAT Study Adding Lyso-Thermosensitive Liposomal Doxorubicin to Radiofrequency Ablation in Patients with Unresectable Hepatocellular Carcinoma Lesions 期刊论文
2018, 卷号: 24, 期号: 1, 页码: 73-83
作者:  Tak, Won Young;  Lin, Shi-Ming;  Wang, Yijun;  Zheng, Jiasheng;  Vecchione, Aldo
收藏  |  浏览/下载:5/0  |  提交时间:2020/01/03
Observational registry of sorafenib use in clinical practice across Child-Pugh subgroups: The GIDEON study 期刊论文
JOURNAL OF HEPATOLOGY, 2016, 卷号: 65, 期号: 6
作者:  Marrero, Jorge A.;  Kudo, Masatoshi;  Venook, Alan P.;  Ye, Sheng-Long;  Bronowicki, Jean-Pierre
收藏  |  浏览/下载:10/0  |  提交时间:2019/12/05
TACE Treatment in Patients with Sorafenib-treated Unresectable Hepatocellular Carcinoma in Clinical Practice: Final Analysis of GIDEON 期刊论文
RADIOLOGY, 2016, 卷号: 279, 期号: 2
作者:  Kudo, Masatoshi;  Lencioni, Riccardo;  Heldner, Stephanie;  Lehr, Robert;  Nakajima, Keiko
收藏  |  浏览/下载:3/0  |  提交时间:2019/12/05
Global GIDEON data: Subgroup analysis of sorafenib dosing pattern in patients with unresectable hepatocellular carcinoma 会议论文
作者:  Kudo, Masatoshi;  Ye, Sheng-Long;  Nakajima, Keiko;  Lencioni, Riccardo
收藏  |  浏览/下载:10/0  |  提交时间:2019/12/06
Regional differences in sorafenib-treated patients with hepatocellular carcinoma: GIDEON observational study 期刊论文
LIVER INTERNATIONAL, 2016, 卷号: 36, 期号: 8
作者:  Kudo, Masatoshi;  Lencioni, Riccardo;  Marrero, Jorge A.;  Venook, Alan P.;  Bronowicki, Jean-Pierre
收藏  |  浏览/下载:4/0  |  提交时间:2019/12/06
Final analysis of GIDEON (Global Investigation of Therapeutic Decisions in Hepatocellular Carcinoma [HCC] and of Its Treatment with Sorafenib [Sor]) in >3000 Sortreated patients (pts): Clinical findings in pts with liver dysfunction 会议论文
作者:  Marrero, Jorge A.;  Lencioni, Riccardo;  Ye, Sheng-Long;  Kudo, Masatoshi;  Bronowicki, Jean-Pierre
收藏  |  浏览/下载:2/0  |  提交时间:2019/12/19
Safety and outcomes by disease etiology in sorafenib-treated uHCC patients in clinical practice: final analysis of GIDEON (Global Investigation of therapeutic DEcisions in hepatocellular carcinoma and Of its treatment with sorafeNib) 会议论文
作者:  Sanyal, Arun J.;  Lencioni, Riccardo;  Ye, Sheng-Long;  Kudo, Masatoshi;  Venook, Alan
收藏  |  浏览/下载:4/0  |  提交时间:2019/12/19
First interim analysis of the GIDEON (Global Investigation of therapeutic DEcisions in hepatocellular carcinoma and of its treatment with sorafeNib) non-interventional study 期刊论文
International Journal of Clinical Practice, 2012, 卷号: 66, 期号: 7
作者:  Lencioni, Riccardo A./35392831700[0];  Kudo, Masatoshi/55216757300[1];  Ye, Shenglong/7202088340[2];  Bronowicki, Jean Pierre/7004535150[3];  Chen, Xiaoping/57020399100[4]
收藏  |  浏览/下载:3/0  |  提交时间:2019/12/19
SECOND INTERIM ANALYSIS OF GIDEON (GLOBAL INVESTIGATION OF THERAPEUTIC DECISIONS IN UNRESECTABLE HCC [UHCC] AND OF ITS TREATMENT WITH SORAFENIB): MULTIREGIONAL VARIATION IN PATIENT (PT) CHARACTERISTICS, PREVIOUS TREATMENT HISTORY, AND SORAFENIB (SOR) USE 会议论文
作者:  Kudo, Masatoshi;  Ye, Sheng-Long;  Venook, Alan;  Marrero, Jorge A.;  Nakajima, Keiko
收藏  |  浏览/下载:3/0  |  提交时间:2019/12/19


©版权所有 ©2017 CSpace - Powered by CSpace